NCT04926376View on ClinicalTrials.gov

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions
Hepatocellular Carcinoma Non-resectableMetastatic Colorectal CancerLiver Cancer
Interventions
DEVICE

Eye90 Microspheres

Y90 glass microspheres

Trial Locations (1)

Unknown

Auckland District Health Board, Grafton

Sponsors

Lead Sponsor

ABK Biomedical
All Listed Sponsors
lead

ABK Biomedical

INDUSTRY

NCT04926376 - Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC) | Biotech Hunter | Biotech Hunter